These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24157876)

  • 21. The exon 12-containing LHX6 isoforms promote cervical cancer cell proliferation by regulating the MAPK signaling pathway.
    Wang L; Zhou Y; Cao C; Lin S; Zhi W; Zhang D; Li J; Wei R; Jiang G; Xu H; Wang X; Xi L; Wu P
    Cancer Med; 2022 Oct; 11(19):3657-3673. PubMed ID: 35384355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis.
    Hwang JA; Kim Y; Hong SH; Lee J; Cho YG; Han JY; Kim YH; Han J; Shim YM; Lee YS; Kim DH
    PLoS One; 2013; 8(11):e79634. PubMed ID: 24265783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD81 is a candidate tumor suppressor gene in human gastric cancer.
    Yoo TH; Ryu BK; Lee MG; Chi SG
    Cell Oncol (Dordr); 2013 Apr; 36(2):141-53. PubMed ID: 23264205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.
    Zhang J; Wen X; Liu N; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Zhang PP; Ma J; Sun Y
    J Exp Clin Cancer Res; 2017 Oct; 36(1):147. PubMed ID: 29052525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.
    Liu X; Zhang X; Zhan Q; Brock MV; Herman JG; Guo M
    Cancer Biol Ther; 2012 Oct; 13(12):1152-7. PubMed ID: 22892849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis.
    Le X; Mu J; Peng W; Tang J; Xiang Q; Tian S; Feng Y; He S; Qiu Z; Ren G; Huang A; Lin Y; Tao Q; Xiang T
    Theranostics; 2020; 10(21):9495-9511. PubMed ID: 32863941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1927-46. PubMed ID: 27393180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RASSF10 is epigenetically inactivated and induces apoptosis in lung cancer cell lines.
    Wang Y; Ma T; Bi J; Song B; Zhou Y; Zhang C; Gao M
    Biomed Pharmacother; 2014 Apr; 68(3):321-6. PubMed ID: 24433832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
    Shin SH; Park SY; Kang GH
    Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
    Liu W; Huang Y; Wang D; Han F; Chen H; Chen J; Jiang X; Cao J; Liu J
    Oncogene; 2021 Jul; 40(26):4468-4485. PubMed ID: 34108620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer.
    Yu Y; Yin D; Hoque MO; Cao B; Jia Y; Yang Y; Guo M
    Tumour Biol; 2012 Apr; 33(2):307-14. PubMed ID: 22095135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
    Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
    Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal pentraxin II (NPTX2) hypermethylation promotes cell proliferation but inhibits cell cycle arrest and apoptosis in gastric cancer cells by suppressing the p53 signaling pathway.
    Xu G; Fan L; Zhao S; OuYang C
    Bioengineered; 2021 Dec; 12(1):1311-1323. PubMed ID: 33896384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.
    Dallol A; Forgacs E; Martinez A; Sekido Y; Walker R; Kishida T; Rabbitts P; Maher ER; Minna JD; Latif F
    Oncogene; 2002 May; 21(19):3020-8. PubMed ID: 12082532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation-dependent silencing of tumor-selective apoptosis-inducing TRAIL by DNA hypermethylation is antagonized by decitabine.
    Lund P; Kotova I; Kedinger V; Khanwalkar H; Voltz E; Hahn WC; Gronemeyer H
    Mol Cancer Ther; 2011 Sep; 10(9):1611-23. PubMed ID: 21697397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells.
    Kim NY; Kim MC; Kim Y
    Cancer Gene Ther; 2016 Dec; 23(12):425-432. PubMed ID: 27857059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
    Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
    Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.